An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could result in users injecting substances of unknown origin.
Some professionals stated the demand for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.
Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer laws, risking fines, legal action or prison.
Service Reaction and Material Removal
According to TikTok, the service has removed problematic material and prohibited associated hashtags and query recommendations. The company said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.
Online Marketplace Operations
Research also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, positive reviews and detailed instructions for preparing or injecting at residence.
After minutes of joining one community, a vendor shared WhatsApp details, where most purchases occur. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Details and Pricing
Within these groups, messages show black plastic packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to possibly serious medical dangers”.
